Vasculitis associated with VEXAS syndrome: A literature review
Vasculitis is an inflammatory disorder of the blood vessels that causes damage to a wide variety of organs through tissue ischemia. Vasculitis is classified according to the size (large, medium, or small) of the blood vessels. In 2020, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic)...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.983939/full |
| _version_ | 1811215817585459200 |
|---|---|
| author | Ryu Watanabe Manami Kiji Motomu Hashimoto |
| author_facet | Ryu Watanabe Manami Kiji Motomu Hashimoto |
| author_sort | Ryu Watanabe |
| collection | DOAJ |
| description | Vasculitis is an inflammatory disorder of the blood vessels that causes damage to a wide variety of organs through tissue ischemia. Vasculitis is classified according to the size (large, medium, or small) of the blood vessels. In 2020, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, a novel autoinflammatory syndrome, was described. Somatic mutations in methionine-41 of UBA1, the major E1 enzyme that initiates ubiquitylation, are attributed to this disorder. This new disease entity connects seemingly unrelated conditions: inflammatory syndromes (relapsing chondritis, Sweet's syndrome, or neutrophilic dermatosis) and hematologic disorders (myelodysplastic syndrome or multiple myeloma). Notably, such patients sometimes develop vasculitis, such as giant cell arteritis and polyarteritis nodosa, and fulfill the corresponding classification criteria for vasculitis. Thus, vasculitis can be an initial manifestation of VEXAS syndrome. In this research topic exploring the link between autoinflammatory diseases and vasculitis, we first provide an overview of the disease mechanisms and clinical phenotypes of VEXAS syndrome. Then, a literature review using the PubMed database was performed to delineate the clinical characteristics of vasculitis associated with VEXAS syndrome. Finally, the therapeutic options and unmet needs of VEXAS syndrome are discussed. |
| first_indexed | 2024-04-12T06:28:46Z |
| format | Article |
| id | doaj.art-0b60054e927f4ed59f0545b49f0f190e |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-04-12T06:28:46Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-0b60054e927f4ed59f0545b49f0f190e2022-12-22T03:44:04ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-08-01910.3389/fmed.2022.983939983939Vasculitis associated with VEXAS syndrome: A literature reviewRyu WatanabeManami KijiMotomu HashimotoVasculitis is an inflammatory disorder of the blood vessels that causes damage to a wide variety of organs through tissue ischemia. Vasculitis is classified according to the size (large, medium, or small) of the blood vessels. In 2020, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, a novel autoinflammatory syndrome, was described. Somatic mutations in methionine-41 of UBA1, the major E1 enzyme that initiates ubiquitylation, are attributed to this disorder. This new disease entity connects seemingly unrelated conditions: inflammatory syndromes (relapsing chondritis, Sweet's syndrome, or neutrophilic dermatosis) and hematologic disorders (myelodysplastic syndrome or multiple myeloma). Notably, such patients sometimes develop vasculitis, such as giant cell arteritis and polyarteritis nodosa, and fulfill the corresponding classification criteria for vasculitis. Thus, vasculitis can be an initial manifestation of VEXAS syndrome. In this research topic exploring the link between autoinflammatory diseases and vasculitis, we first provide an overview of the disease mechanisms and clinical phenotypes of VEXAS syndrome. Then, a literature review using the PubMed database was performed to delineate the clinical characteristics of vasculitis associated with VEXAS syndrome. Finally, the therapeutic options and unmet needs of VEXAS syndrome are discussed.https://www.frontiersin.org/articles/10.3389/fmed.2022.983939/fullautoinflammatory diseasegiant cell arteritisleukocytoclastic vasculitisvasculitisVEXAS syndrome |
| spellingShingle | Ryu Watanabe Manami Kiji Motomu Hashimoto Vasculitis associated with VEXAS syndrome: A literature review Frontiers in Medicine autoinflammatory disease giant cell arteritis leukocytoclastic vasculitis vasculitis VEXAS syndrome |
| title | Vasculitis associated with VEXAS syndrome: A literature review |
| title_full | Vasculitis associated with VEXAS syndrome: A literature review |
| title_fullStr | Vasculitis associated with VEXAS syndrome: A literature review |
| title_full_unstemmed | Vasculitis associated with VEXAS syndrome: A literature review |
| title_short | Vasculitis associated with VEXAS syndrome: A literature review |
| title_sort | vasculitis associated with vexas syndrome a literature review |
| topic | autoinflammatory disease giant cell arteritis leukocytoclastic vasculitis vasculitis VEXAS syndrome |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.983939/full |
| work_keys_str_mv | AT ryuwatanabe vasculitisassociatedwithvexassyndromealiteraturereview AT manamikiji vasculitisassociatedwithvexassyndromealiteraturereview AT motomuhashimoto vasculitisassociatedwithvexassyndromealiteraturereview |